These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 7511039)

  • 1. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
    Pollack A; Zagars GK; el-Naggar AK; Terry NH
    Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
    Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
    Borre M; Høyer M; Nerstrøm B; Overgaard J
    Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation.
    Pollack A; Troncoso P; Zagars GK; von Eschenbach AC; Mak AC; Wu CS; Terry NH
    Prostate; 1997 Apr; 31(1):21-8. PubMed ID: 9108882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
    Khoo VS; Pollack A; Cowen D; Joon DL; Patel N; Terry NH; Zagars GK; von Eschenbach AC; Meistrich ML; Troncoso P
    Prostate; 1999 Nov; 41(3):166-72. PubMed ID: 10517874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA; O'Toole RV; Young DC; Drago JR
    Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
    Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H
    J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
    Zagars GK
    J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy.
    Keyes M; Macaulay C; Hayes M; Korbelik J; Morris WJ; Palcic B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):829-34. PubMed ID: 23688814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
    Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
    Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In treating localized prostate cancer the efficacy of cryoablation is independent of DNA ploidy type.
    Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
    Technol Cancer Res Treat; 2004 Jun; 3(3):253-7. PubMed ID: 15161318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
    Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
    Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
    Zagars GK; Pollack A
    Urology; 1995 Mar; 45(3):476-83. PubMed ID: 7533459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy.
    Lankford SP; Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):327-33. PubMed ID: 9226319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.